News

Medicines recall: Erythromycin 250mg tablets

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a Class 4 Medicines Defect Notification concerning one batch of Erythromycin Stearate 250mg tablets (Erythrocin®),

WhatsApp